• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clinical preparedness for severe pneumonia with highly pathogenic avian influenza A (H5N1): Experiences with cases in Vietnam

tetano

Editor, Senior Moderator
Respir Investig. 2012 Dec;50(4):140-50. doi: 10.1016/j.resinv.2012.08.005. Epub 2012 Sep 29.
Clinical preparedness for severe pneumonia with highly pathogenic avian influenza A (H5N1): Experiences with cases in Vietnam.
Kudo K, Binh NG, Manabe T, Co DX, Tuan ND, Izumi S, Takasaki J, Minh DH, Thuy PT, Van VT, Hanh TT, Chau NQ.
Source

National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan; Waseda University, 1-21-1 Nishi-Waseda, Shinjuku-ku, Tokyo 169-0051, Japan. Electronic address: kudo@aoni.waseda.jp.
Abstract
BACKGROUND:

Avian influenza A (H5N1) in human presents a global pandemic threat, and preparedness is urgently required in high-risk countries.
METHODS:

A retrospective chart review was conducted on 8 patients with H5N1 infection (aged 2-30 years; 3 fatal) who were hospitalized in Bach Mai Hospital (BMH), Vietnam, or in affiliated hospitals with consultation by physicians in BMH between 2007 and 2010. Demographic background, chest radiographs, and clinical and laboratory data were evaluated to determine the critical issues in relation to clinical outcomes. Treatment of 4 patients with acute respiratory distress syndrome (ARDS) (2 fatal) was assessed for renal replacement therapy using continuous hemodiafiltration (CHDF), polymyxin B-immobilized (PMX) hemoperfusion, or their combination.
RESULTS:

Patients had direct contact with dead/sick poultry infected with H5N1 virus or lived in areas where H5N1 poultry outbreaks had been reported at the same time as their illness. Time to initiation of oseltamivir from symptom onset was 2-6 days for survivors and 7-9 days for non-survivors. All patients except one had infiltrative shadows on chest radiographs on admission. Patients with delayed treatment developed ARDS. Renal replacement therapy contributed to patient survival, with improvement of oxygenation and a dramatic decrease in serum cytokine levels if initiated earlier.
CONCLUSIONS:

Understanding local H5N1 poultry outbreaks and chest radiography assist early diagnosis and initiation of antiviral treatment. Developing a network among local and tertiary care hospitals can reduce the time to initiation of treatment. CHDF and PMX hemoperfusion are possible candidates for effective treatment of ARDS with H5N1 if applied earlier.

Copyright ? 2012 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.

PMID:
23199978
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23199978
 
Back
Top Bottom